1.74

9.43% 0.15

MAIA Biotechnology Inc (MAIA)

Overview News Price History Discussions Forecast

MAIA Biotechnology Inc stock is traded at $1.74, with a volume of 2.40M. It is up +9.43% in the last 24 hours and up +41.46% over the past month. MAIA Biotechnology, Inc., a clinical stage biotechnology company, engages in the discovery, development, and commercialization of therapies targeting cancer. The company's lead product candidate is THIO, a telomere-targeting agent that is in Phase II clinical study to evaluate its activity in patients with non-small cell lung cancer. It is also developing second generation telomere targeting agents. MAIA Biotechnology, Inc. was incorporated in 2018 and is headquartered in Chicago, Illinois.

Previous Close:

$1.59

Open:

$1.6

24h Volume:

2.40M

Relative Volume:

3.43

Market Cap:

$64.44M

Revenue:

Net Income/Loss:

$-25.94M

P/E Ratio:

-1.2609

EPS:

-1.38

Net Cash Flow:

$-15.79M

1W Performance:

+6.75%

1M Performance:

+41.46%

6M Performance:

+1.75%

1Y Performance:

-13.86%

1-Day Range:

$1.60

$1.89

1-Week Range:

$1.49

$1.89

52-Week Range:

$0.87

$2.74

MAIA Biotechnology Inc Stock (MAIA) Company Profile

Name

MAIA Biotechnology Inc

Sector

Healthcare (1115)

Industry

Biotechnology (624)

Phone

312 416 8592

Address

444 West Lake Street, Suite 1700, Chicago

Employee

Twitter

Next Earnings Date

2025-08-08

Latest SEC Filings

MAIA's Discussions on Twitter

Compare MAIA with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
MAIA MAIA Biotechnology Inc	1.74	58.88M	0	-25.94M	-15.79M	-1.38
VRTX Vertex Pharmaceuticals Inc	441.36	111.36B	11.74B	3.68B	3.34B	14.19
REGN Regeneron Pharmaceuticals Inc	733.04	77.98B	14.25B	4.58B	3.88B	41.77
ARGX Argen X Se Adr	800.01	50.33B	3.06B	1.28B	447.35M	19.67
ALNY Alnylam Pharmaceuticals Inc	359.27	47.46B	3.21B	43.57M	221.36M	0.2405
ONC Beone Medicines Ltd Adr	338.19	37.43B	4.98B	69.59M	525.67M	0.5197

MAIA Biotechnology Inc Stock (MAIA) Latest News

Jan 17, 2026

MAIA Biotechnology (NYSEAMERICAN:MAIA) Shares Up 9.4% – Time to Buy? - Defense World

Jan 17, 2026

Jan 15, 2026

Trend Report: Should I buy BOSC stock nowJuly 2025 Highlights & AI Powered Trade Plan Recommendations - baoquankhu1.vn

Jan 15, 2026

Jan 14, 2026

MAIA Biotechnology (MAIA) Price Target Decreased by 15.37% to 10.48 - Nasdaq

Jan 14, 2026

Jan 13, 2026

MAIA Biotechnology Highlights Strategy in New Investor Presentation - TipRanks

Jan 13, 2026

Jan 12, 2026

Smith Stan buys MAIA Biotechnology shares worth $9,958 By Investing.com - Investing.com Australia

Jan 12, 2026

Smith Stan buys MAIA Biotechnology shares worth $9,958 - Investing.com

Jan 12, 2026

Jan 10, 2026

Will MAIA Biotechnology Inc. stock sustain dividend payoutsJuly 2025 Opening Moves & Risk Managed Investment Strategies - Улправда

Jan 10, 2026

Jan 09, 2026

Will MAIA Biotechnology Inc. stock deliver compounding returns2025 Fundamental Recap & AI Forecasted Entry and Exit Points - Улправда

Jan 09, 2026

Jan 08, 2026

Can MAIA Biotechnology Inc. stock deliver strong annual returnsWeekly Trade Recap & Expert Curated Trade Ideas - Улправда

Jan 08, 2026

Jan 05, 2026

MAIA Biotechnology (MAIA) director granted 24,060 options under 2021 plan - Stock Titan

Jan 05, 2026

MAIA Biotechnology (MAIA) director reports grant of 29,216 stock options - Stock Titan

Jan 05, 2026

MAIA Biotechnology (MAIA) director receives 25,206 stock options exercisable at $1.53 - Stock Titan

Jan 05, 2026